On June 23, the Empower Clinics stock had soared to Can$0.7100 a share from Can$0.6300. However, the stock corrected sharply since then and ultimately dropped down to Can$0.4350. From July 19, the share price slowly recovered by 28%; later, it plummeted to Can$0.5000.Empower clinics inc., an integrated healthcare company that serves patients through medical centers, telemedicine platforms, and a high-complexity medical diagnostics laboratory that processes thousands of COVID-19 specimens, is pleased to announce that its yearly Report on Form 20-F for the fiscal year ended December 31, 2020, is now available and prepared following International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board, was filed with the U.S. Securities and Trade Commission and on the OTC Markets on July 21, 2021.
Foreign private issuers that list equity shares on U.S. markets must file Form 20-F as their principal disclosure form. It’s usually reported as an annual report with the Securities and Exchange Commission. The Securities Act and the Exchange Act require Form 20-F to unify reporting standards so that investors may compare the stocks of foreign-based businesses to those of US-based corporations.